Solara Active Pharma Sciences share price
You have to be logged in to add this to Watchlist.- ₹517.75(-0.28%)January 21, 2026 15:29:16 PM IST
- NSE
- BSE
- Vol : 79.78 K (NSE + BSE)Last 20 day avg : 56.48 K
Solara Active Pharma Sciences is trading -0.28% lower at Rs 517.75 as compared to its last closing price. Solara Active Pharma Sciences has been trading in the price range of 532.70 & 516.90. Solara Active Pharma Sciences has given -7.96% in this year & -5.24% in the last 5 days. Solara Active Pharma Sciences has TTM P/E ratio 502.46 as compared to the sector P/E of 22.59.The company posted a net profit of -10.10 Crores in its last quarter.Listed peers of Solara Active Pharma Sciences include Sun Pharmaceutical Industries (-0.12%), Cipla (-0.60%), Torrent Pharmaceuticals (-0.50%).The Mutual Fund holding in Solara Active Pharma Sciences was at 1.18% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Solara Active Pharma Sciences was at 11.98% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 21, 2026, 05:14 PM UTC
- BetaHigh volatility1.76Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.73The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values2.28The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG RatioIndicates undervaluation-6.39The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,610.10 | -0.12 | 3,86,307.82 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Bearish | 1,369.55 | -0.60 | 1,11,043.44 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 3,955.00 | -0.50 | 1,33,849.80 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bearish | 1,155.50 | -0.98 | 96,437.03 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bearish | 6,004.65 | -0.08 | 1,59,494.19 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-05 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-15 | Audited Results |
| 2025-04-02 | Others |
| 2025-03-26 | Rights Issue & Others |
- IndustryBiotechnology & Drugs
- ISININE624Z01016
- BSE Code541540
- NSE CodeSOLARA
Solara Active Pharma Sciences is trading at 517.75 as on Wed Jan 21 2026 09:59:16. This is -0.28% lower as compared to its previous closing price of 519.20.
The market capitalization of Solara Active Pharma Sciences is 1864.86 Cr as on Wed Jan 21 2026 09:59:16.
The 52 wk high for Solara Active Pharma Sciences is 734.20 whereas the 52 wk low is 441.10
Solara Active Pharma Sciences can be analyzed on the following key metrics -
- TTM P/E: 502.46
- Sector P/E: 22.59
- Dividend Yield: 0.00%
- D/E ratio: 0.51
Solara Active Pharma Sciences reported a net profit of 0.54 Cr in 2025.
The Mutual Fund Shareholding was 1.18% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Solara Active Pharma Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.